Stocks & Investing
Stocks and Investing
Stocks and Investing
Fri, May 12, 2023
[ Fri, May 12th 2023
] - WOPRAI
[ Fri, May 12th 2023
] - WOPRAI
[ Fri, May 12th 2023
] - WOPRAI
[ Fri, May 12th 2023
] - WOPRAI
[ Fri, May 12th 2023
] - WOPRAI
[ Fri, May 12th 2023
] - WOPRAI
[ Fri, May 12th 2023
] - WOPRAI
[ Fri, May 12th 2023
] - WOPRAI
[ Fri, May 12th 2023
] - WOPRAI
[ Fri, May 12th 2023
] - WOPRAI
[ Fri, May 12th 2023
] - WOPRAI
[ Fri, May 12th 2023
] - WOPRAI
[ Fri, May 12th 2023
] - WOPRAI
[ Fri, May 12th 2023
] - WOPRAI
[ Fri, May 12th 2023
] - WOPRAI
[ Fri, May 12th 2023
] - WOPRAI
[ Fri, May 12th 2023
] - WOPRAI
[ Fri, May 12th 2023
] - WOPRAI
[ Fri, May 12th 2023
] - WOPRAI
[ Fri, May 12th 2023
] - WOPRAI
[ Fri, May 12th 2023
] - WOPRAI
[ Fri, May 12th 2023
] - WOPRAI
[ Fri, May 12th 2023
] - WOPRAI
[ Fri, May 12th 2023
] - WOPRAI
[ Fri, May 12th 2023
] - WOPRAI
[ Fri, May 12th 2023
] - WOPRAI
[ Fri, May 12th 2023
] - WOPRAI
[ Fri, May 12th 2023
] - WOPRAI
Yatin Suneja Maintained (ANAB) at Strong Buy with Increased Target to $45 on, May 12th, 2023
Yatin Suneja of Guggenheim, Maintained "AnaptysBio, Inc." (ANAB) at Strong Buy with Increased Target from $44 to $45 on, May 12th, 2023.
Yatin has made no other calls on ANAB in the last 4 months.
There is 1 other peer that has a rating on ANAB. Out of the 1 peers that are also analyzing ANAB, 0 agree with Yatin's Rating of Hold.
This is the rating of the analyst that currently disagrees with Yatin
- Anupam Rama of "JP Morgan" Maintained at Sell with Decreased Target to $31 on, Wednesday, April 12th, 2023
